Literature DB >> 34404233

Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome.

Haiyan Chu1, Anastasia Sacharidou1, An Nguyen1, Chun Li1, Ken L Chambliss1, Jane E Salmon2, Yu-Min Shen3, Julie Lo4, Gustavo W Leone5, Joachim Herz6, David Y Hui7, Denise K Marciano3,8, Vikki M Abrahams9, Bryony V Natale10,11, Alina P Montalbano12, Xue Xiao13, Lin Xu13, David R Natale10,11, Philip W Shaul1, Chieko Mineo1,8.   

Abstract

[Figure: see text].

Entities:  

Keywords:  antiphospholipid syndrome; endoglin; placenta; preeclampsia; proteinuria; trophoblasts

Mesh：

Substances：

Year:  2021        PMID： 34404233      PMCID： PMC8448973          DOI： 10.1161/CIRCRESAHA.120.318941

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   23.213


  76 in total

1.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.

Authors:  Joshua E Elias; Steven P Gygi
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

2.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

3.  Cloud CPFP: a shotgun proteomics data analysis pipeline using cloud and high performance computing.

Authors:  David C Trudgian; Hamid Mirzaei
Journal:  J Proteome Res       Date:  2012-10-29       Impact factor: 4.466

4.  Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.

Authors:  Lukas J A C Hawinkels; Patricia Kuiper; Eliza Wiercinska; Hein W Verspaget; Zhen Liu; Evangelia Pardali; Cornelis F M Sier; Peter ten Dijke
Journal:  Cancer Res       Date:  2010-04-27       Impact factor: 12.701

Review 5.  The significance of autoantibodies against β2-glycoprotein I.

Authors:  Philip G de Groot; Rolf T Urbanus
Journal:  Blood       Date:  2012-05-02       Impact factor: 22.113

6.  Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Authors:  R Cervera; R Serrano; G J Pons-Estel; L Ceberio-Hualde; Y Shoenfeld; E de Ramón; V Buonaiuto; S Jacobsen; M M Zeher; T Tarr; A Tincani; M Taglietti; G Theodossiades; E Nomikou; M Galeazzi; F Bellisai; P L Meroni; R H W M Derksen; P G D de Groot; M Baleva; M Mosca; S Bombardieri; F Houssiau; J-C Gris; I Quéré; E Hachulla; C Vasconcelos; A Fernández-Nebro; M Haro; Z Amoura; M Miyara; M Tektonidou; G Espinosa; M L Bertolaccini; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2014-01-24       Impact factor: 19.103

7.  Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation.

Authors:  J Chen; B L Martin; D L Brautigan
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

8.  Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.

Authors:  Jin He; Troy A Luster; Philip E Thorpe
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  Hypertensive disorders and severe obstetric morbidity in the United States.

Authors:  Elena V Kuklina; Carma Ayala; William M Callaghan
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

10.  Reduced Uteroplacental Perfusion Pressure (RUPP) causes altered trophoblast differentiation and pericyte reduction in the mouse placenta labyrinth.

Authors:  Bryony V Natale; Prutha Mehta; Priscilla Vu; Christina Schweitzer; Katarina Gustin; Ramie Kotadia; David R C Natale
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379
View more
  2 in total

Review 1.  Animal Models of Cardiovascular Complications of Pregnancy.

Authors:  Zolt Arany; Denise Hilfiker-Kleiner; S Ananth Karumanchi
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

2.  Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome.

Authors:  Manuela Velásquez; Luisa F Peláez; Mauricio Rojas; Raúl Narváez-Sánchez; Jesús A Velásquez; Carlos Escudero; Sebastián San Martín; Ángela P Cadavid
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.